天瑞仪器(300165) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥209,096,064.53, an increase of 1.48% compared to the same period last year[2]. - Net profit attributable to shareholders for Q3 2024 was ¥8,047,909.17, representing a significant increase of 165.85% year-on-year[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥8,094,257.02, up 168.22% from the previous year[2]. - The company's basic earnings per share for Q3 2024 was ¥0.0162, a 165.68% increase compared to the same period last year[2]. - The net profit for Q3 2024 was -4,134,938.90 CNY, a significant decrease compared to the net profit of 10,605,730.33 CNY in Q3 2023, representing a decline of approximately 138.9%[18]. - The total profit for the period was 3,794,411.13 CNY, down from 17,631,326.21 CNY in Q3 2023, indicating a decline of approximately 78.5%[18]. - The company reported a basic and diluted earnings per share of -0.0138 CNY, compared to 0.0228 CNY in the previous year, reflecting a negative shift in profitability[19]. Cash Flow and Assets - The net cash flow from operating activities for the year-to-date was ¥50,463,310.85, an increase of 122.50% compared to the same period last year[2]. - The cash flow from operating activities showed a net increase of 50,463,310.85 CNY, contrasting with a net outflow of -224,312,179.37 CNY in Q3 2023[20]. - The cash flow from investing activities showed a net outflow of -13,437,298.07 CNY, compared to -12,294,943.00 CNY in the same period last year[21]. - The financing activities resulted in a net cash outflow of -160,315,711.86 CNY, contrasting with a net inflow of 55,489,669.10 CNY in Q3 2023[21]. - Total assets as of September 30, 2024, were ¥3,627,951,780.66, a decrease of 3.42% from the end of the previous year[2]. - Cash and cash equivalents decreased to 116,070,501.80 CNY from 239,169,479.20 CNY, a decline of 51.54%[14]. - The cash and cash equivalents at the end of the period were 116,070,501.80 CNY, down from 228,680,807.75 CNY at the end of Q3 2023, a decrease of approximately 49.2%[21]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 31,090, with the largest shareholder, Liu Zhaogui, holding 16.13% of shares[9]. - Liu Zhaogui holds 79,914,203 shares, of which 59,935,652 are under lock-up conditions[9]. - The top ten shareholders include Guangzhou Lidu Virtual Reality Technology Partnership, holding 5.01% with 24,825,137 shares[9]. - The company has 74,979,615 shares under lock-up conditions at the end of the reporting period, with 3,425 shares released during the period[11]. - The top ten shareholders' participation in margin trading shows no significant changes compared to the previous period[10]. Regulatory and Compliance Issues - The company is currently under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws[12]. - The company has disclosed its compliance with regulatory requirements during the ongoing investigation[13]. - The company has not received any conclusive opinions or decisions regarding the investigation as of now[13]. - If the investigation leads to administrative penalties that trigger major violations, the company's stock may face forced delisting[13]. - The company actively cooperates with the investigation and adheres to information disclosure obligations[13]. Operational Metrics - Total revenue for the period was 588,862,093.80 CNY, a decrease of 8.27% compared to 641,978,936.46 CNY in the previous period[17]. - Operating costs amounted to 571,822,154.40 CNY, down from 643,353,898.58 CNY, reflecting a reduction of approximately 11.14%[17]. - Accounts receivable increased to 433,199,874.09 CNY from 377,904,493.54 CNY, representing a growth of 14.66%[14]. - Inventory decreased significantly to 431,313,992.76 CNY from 541,417,298.39 CNY, a reduction of 20.41%[14]. - Non-current assets totaled 456,872,223.84 CNY, down from 472,083,932.13 CNY, indicating a decrease of 3.23%[15]. - Total liabilities decreased to 2,197,795,864.34 CNY from 2,322,947,416.40 CNY, a reduction of 5.37%[16]. - The company's equity attributable to shareholders was 1,384,727,884.10 CNY, reflecting stability compared to the previous period[16]. - Research and development expenses were reported at 55,991,492.78 CNY, slightly up from 55,617,655.65 CNY, indicating a focus on innovation[17]. - The company plans to enhance market expansion strategies and invest in new product development to drive future growth[16].